Skip to main content

Table 1 Studies included in the pooled analysis

From: Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta–analysis

Author(Year)

Sample size(n)

Age of participants

Dosage

Location

Quality score

Risk Ratio

%Weight using FEM*

Madhi et al. (2011) [19]

547

<4 months

10–20 mg/kg

South Africa and Botswana

5A

0.98(0.7,1.39)

32.4%

Madhi et al. (2011) [19]

806

<4 months

10–20 mg/kg

South Africa and Botswana

5A

0.86(0.57,1.29)

22.8%

Zar et al. (2007) [18]

263

<51 months

10(8–12)mg/kg

South Africa

5A

0.28(0.1,0.78)

3.6%

Gupta et al. (1993) [24]

167

5–15 years

15 mg/kg

India

1D

0.61(0.3,1.25)

7.5%

Debre et al. (1973) [22]

2,307

5–14 years

5–15 mg/kg

France

1D

0.40(0.15,1.05)

4.0%

Egsmose et al. (1965) [20]

406

0–15 years

5–10 mg/kg

Kenya

5A

0.38(0.16,0.88)

5.2%

Comstock et al. (1962) [23]

3,074

2 months–15 years

4–8 mg/kg

Alaska

5A

0.33(0.07,1.64)

1.5%

Mount et al. (1961) [25]

2,750

0–15 years

4–6 mg/kg

USA, Canada, Mexico

5A

0.40(0.27,0.61)

22.9%

Total

10,320

     

100%

  1. *FEM-Fixed Effects Model.